Ultrasound imaging firm MAUI has introduced a $4 million contract with the Division of Protection (U.S. Military Medical Analysis and Improvement Command) to help 4 branches of the U.S. army utilizing its autonomous ultrasound expertise for trauma drugs.
The Arizona-based firm The MAUI K3900, which obtained 510(okay) clearance in October, is a distal ultrasound imaging system to be used by healthcare suppliers in pediatric, fetal, stomach, peripheral vascular, grownup cranial, urological, small organ, neonatal Cranial, grownup and pediatric cardiac, intraoperative, musculoskeletal and urological drugs.
David Specht, CEO and co-founder of MAUI Imaging, mentioned in a press release: “As U.S. army contracts and our expertise turn into extra seen on the broader stage, we determined it was time to return out of hiding and exhibit what we have been engaged on. factor.
“The suggestions we obtained from physicians and technicians highlighted the vital want for a brand new ultrasound-based expertise able to imaging all kinds of tissue. This want is most evident in trauma drugs, the place is a significant focus of Maui College’s collaborative improvement efforts.
bigger pattern
Different corporations providing distant imaging expertise embrace digital ultrasound corporations Butterfly Community, producer of handheld smartphone-connected ultrasound techniques.
In January, Butterfly obtained The corporate’s third-generation ultrasound system, Butterfly IQ3, has obtained FDA 510(okay) clearance.
Butterfly iQ3 is a point-of-care ultrasound system that gives whole-body imaging utilizing a single probe. Healthcare suppliers scan sufferers, and Butterfly’s software program (obtainable on iOS and Android) makes use of synthetic intelligence and information processing to research the photographs.
Two months later, the corporate obtained The Butterfly IQ+ ultrasound system obtained EU MDR certification, permitting it to launch its product into the European market.
In April, Butterfly introduced a partnership with AI ultrasound firm ThinkSono allows Butterfly customers to make use of ThinkSono’s AI coaching utility to deal with deep venous thrombosis (DVT).
the identical month, Clarius Cell Well being, which supplies cell ultrasound expertise, has introduced a partnership with ThinkSono to develop a brand new app referred to as ThinkSono Steerage, a synthetic intelligence-enabled app that works with Clarius scanners to enhance DVT detection.
